Related Experiment Videos
Bioactive constituents from Boswellia papyrifera
Atta-ur-Rahman1, Humera Naz, Fadimatou
1H. E. J. Research Institute of Chemistry, International Center for Chemical Sciences, University of Karachi, Karachi-75270, Pakistan.
Journal of Natural Products
|February 26, 2005
Summary
Phytochemical analysis of Boswellia papyrifera yielded new stilbene glycosides and triterpenes. These compounds demonstrated significant inhibition of phosphodiesterase I, xanthine oxidase, and prolyl endopeptidase, indicating potential therapeutic applications.
Area of Science:
- Natural Product Chemistry
- Pharmacology
Background:
- Boswellia papyrifera is a source of bioactive compounds.
- Phytochemical studies are crucial for discovering new therapeutic agents.
Purpose of the Study:
- To isolate and characterize novel compounds from Boswellia papyrifera stem bark.
- To evaluate the biological activities of the isolated compounds.
Main Methods:
- Phytochemical investigation using chromatographic and spectroscopic techniques.
- Enzyme inhibition assays for phosphodiesterase I, xanthine oxidase, and prolyl endopeptidase.
Main Results:
- Two new stilbene glycosides and one new triterpene were identified.
- Isolated stilbene glycosides showed significant inhibition of phosphodiesterase I and xanthine oxidase.
- Isolated triterpenes exhibited prolyl endopeptidase inhibitory activities.
Conclusions:
- Boswellia papyrifera is a rich source of bioactive compounds with potential pharmacological benefits.
- The identified stilbene glycosides and triterpenes warrant further investigation for drug development.